• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管患者的死亡率

Mortality rates in patients with Barrett's oesophagus.

作者信息

Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti S K, Harrison R, Talley N J, Jankowski J

机构信息

Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada.

出版信息

Aliment Pharmacol Ther. 2008 Feb 15;27(4):316-20. doi: 10.1111/j.1365-2036.2007.03582.x. Epub 2007 Dec 6.

DOI:10.1111/j.1365-2036.2007.03582.x
PMID:18062791
Abstract

BACKGROUND

Patients with Barrett's oesophagus are at increased risk of oesophageal adenocarcinoma. Observational studies have suggested increase in overall mortality also but data are conflicting.

AIM

To assess the cause of death in patients with Barrett's oesophagus compared with the general population.

METHODS

Patients with Barrett's oesophagus were identified retrospectively in four hospitals in Leicestershire, UK using electronic endoscopy and histopathology records from 1997 to 2003. Data on deaths from this cohort of patients were identified through the Office of National Statistics and compared with age- and gender-adjusted mortality in the Leicestershire region.

RESULT

In all, 1272 Barrett's patients were identified with 245 deaths in this cohort. Overall mortality was found to be increased [male standardized mortality ratio (SMR) = 552, 95% CI = 466-638; female SMR 455, 95% CI = 357-552]. The main disease areas that were responsible for this increase were oesophageal adenocarcinoma (n = 25, male SMR = 2171, 95% CI = 991-3351; female SMR = 1300, 95% CI = 26-2574), bronchopneumonia (n = 70, male SMR = 146, 95% CI = 55-236; female SMR = 436, 95% CI = 272-601) and ischaemic heart disease (n = 51, male SMR = 186, 95% CI = 97-2748; female SMR = 205, 95% CI = 105-306).

CONCLUSIONS

Patients with Barrett's oesophagus die more commonly of bronchopneumonia and ischaemic heart disease compared with oesophageal adenocarcinoma, and overall mortality in this group may be increased.

摘要

背景

巴雷特食管患者发生食管腺癌的风险增加。观察性研究提示总体死亡率也有所上升,但数据存在矛盾。

目的

评估巴雷特食管患者与普通人群相比的死亡原因。

方法

利用英国莱斯特郡四家医院1997年至2003年的电子内镜检查和组织病理学记录,对巴雷特食管患者进行回顾性识别。通过国家统计局获取该队列患者的死亡数据,并与莱斯特郡地区经年龄和性别调整后的死亡率进行比较。

结果

该队列共识别出1272例巴雷特食管患者,其中245例死亡。总体死亡率升高[男性标准化死亡比(SMR)=552,95%可信区间(CI)=466 - 638;女性SMR 455,95%CI = 357 - 552]。导致死亡率升高的主要疾病领域为食管腺癌(n = 25,男性SMR = 2171,95%CI = 991 - 3351;女性SMR = 1300,95%CI = 26 - 2574)、支气管肺炎(n = 70,男性SMR = 146,95%CI = 55 - 236;女性SMR = 436,95%CI = 272 - 601)和缺血性心脏病(n = 51,男性SMR = 186,95%CI = 97 - 2748;女性SMR = 205,95%CI = 105 - 306)。

结论

与食管腺癌相比,巴雷特食管患者死于支气管肺炎和缺血性心脏病更为常见,且该组患者的总体死亡率可能升高。

相似文献

1
Mortality rates in patients with Barrett's oesophagus.巴雷特食管患者的死亡率
Aliment Pharmacol Ther. 2008 Feb 15;27(4):316-20. doi: 10.1111/j.1365-2036.2007.03582.x. Epub 2007 Dec 6.
2
Mortality in Barrett's oesophagus: results from a population based study.巴雷特食管的死亡率:一项基于人群研究的结果
Gut. 2003 Aug;52(8):1081-4. doi: 10.1136/gut.52.8.1081.
3
Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.食管癌是巴雷特食管患者中不常见的死亡原因。
Gut. 1996 Jul;39(1):5-8. doi: 10.1136/gut.39.1.5.
4
Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.美国一个大型巴雷特食管队列中的癌症发病率和死亡率风险。
Gut. 2018 Mar;67(3):418-529. doi: 10.1136/gutjnl-2016-312223. Epub 2017 Jan 4.
5
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
6
Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study.巴雷特食管患者的死亡率和心血管疾病风险:一项基于人群的全国性队列研究。
Aliment Pharmacol Ther. 2017 Apr;45(7):973-982. doi: 10.1111/apt.13962. Epub 2017 Jan 31.
7
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?巴雷特食管的监测:针对高危人群的策略能否降低食管腺癌的死亡率?
Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184.
8
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.巴雷特食管和胃食管反流患者患食管癌的风险。
Gut. 2004 Aug;53(8):1070-4. doi: 10.1136/gut.2003.028076.
9
Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.巴雷特食管的检出率增加,但食管腺癌的发病率并未上升。
Swiss Med Wkly. 2003 Sep 26;133(37-38):507-14. doi: 10.4414/smw.2003.10274.
10
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县巴雷特食管的流行病学及转归的长期趋势
Gut. 2001 Mar;48(3):304-9. doi: 10.1136/gut.48.3.304.

引用本文的文献

1
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.巴雷特食管早期癌症和高级别异型增生的手术与根治性内镜治疗对比
Cochrane Database Syst Rev. 2020 May 22;5(5):CD007334. doi: 10.1002/14651858.CD007334.pub5.
2
Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.老年人使用质子泵抑制剂:权衡风险与获益——一个由来已久的问题
Curr Gastroenterol Rep. 2019 Dec 5;21(12):65. doi: 10.1007/s11894-019-0732-3.
3
Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden).
队列简介:ESPRESSO(瑞典组织病理学报告强化的流行病学研究)。
Clin Epidemiol. 2019 Jan 14;11:101-114. doi: 10.2147/CLEP.S191914. eCollection 2019.
4
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.埃索美拉唑和阿司匹林在 Barrett 食管(AspECT)中的应用:一项随机析因试验。
Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26.
5
Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma.系统评价与荟萃分析:使用他汀类药物与食管腺癌发病率降低相关。
J Gastrointest Cancer. 2018 Dec;49(4):442-454. doi: 10.1007/s12029-017-9983-0.
6
The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.前瞻性招募的巴雷特食管队列中食管腺癌的风险。
United European Gastroenterol J. 2016 Dec;4(6):754-761. doi: 10.1177/2050640616632419. Epub 2016 Feb 19.
7
Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.美国一个大型巴雷特食管队列中的癌症发病率和死亡率风险。
Gut. 2018 Mar;67(3):418-529. doi: 10.1136/gutjnl-2016-312223. Epub 2017 Jan 4.
8
Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.巴雷特食管的诊断与监测:解决跨大西洋差异
Dig Dis Sci. 2016 Aug;61(8):2185-2193. doi: 10.1007/s10620-016-4138-x. Epub 2016 Apr 1.
9
Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.射频消融治疗 Barrett 食管后食管腺癌的发病率和死亡率原因。
Gastroenterology. 2015 Dec;149(7):1752-1761.e1. doi: 10.1053/j.gastro.2015.08.048. Epub 2015 Aug 29.
10
Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.巴雷特食管和食管腺癌的遗传学见解
Gastroenterology. 2015 Oct;149(5):1142-1152.e3. doi: 10.1053/j.gastro.2015.07.010. Epub 2015 Jul 21.